These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Use of lipid-lowering agents (statins) during pregnancy. Hosokawa A; Bar-Oz B; Ito S Can Fam Physician; 2003 Jun; 49():747-9. PubMed ID: 12836860 [TBL] [Abstract][Full Text] [Related]
9. [The indication for lipid-lowering therapy and its intensity is based on the cardiovascular risk, not on the level of cholesterol]. Parhofer KG MMW Fortschr Med; 2024 Mar; 166(5):52-53. PubMed ID: 38514561 [No Abstract] [Full Text] [Related]
10. OTC statins: a bad decision for public health. Lancet; 2004 May; 363(9422):1659. PubMed ID: 15158622 [No Abstract] [Full Text] [Related]
11. [Residual risk of cardiovascular complications and its reduction with a combination of lipid lowering agents]. Soska V Vnitr Lek; 2011 Mar; 57(3):313-6. PubMed ID: 21495414 [TBL] [Abstract][Full Text] [Related]
13. Never too old for lipid-lowering therapy. Boccara F Arch Cardiovasc Dis; 2021; 114(8-9):524-526. PubMed ID: 34257047 [No Abstract] [Full Text] [Related]
18. Limitations of a meta-analysis investigating the association between cancer and statin use. Iwata H; Aoyama T; Kusumi E; Hamaki T; Kami M Am J Med; 2002 Feb; 112(2):157-8. PubMed ID: 11835959 [No Abstract] [Full Text] [Related]
19. Statins and cancer: a case of meta-uncertainty. Guallar E; Goodman SN Am J Med; 2001 Jun; 110(9):738-40. PubMed ID: 11403761 [No Abstract] [Full Text] [Related]
20. Cheilitis due to treatment with simvastatin. Mehregan DR; Mehregan DA; Pakideh S Cutis; 1998 Oct; 62(4):197-8. PubMed ID: 9798110 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]